Ping Ye Selected Research

Ping Ye Research Topics

Disease

21	Inflammation (Inflammations) 04/2022 - 12/2004
19	Neoplasms (Cancer) 01/2022 - 12/2006
15	Infections 09/2019 - 02/2003
13	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 02/2005
13	Hypertension (High Blood Pressure) 01/2020 - 12/2003
12	Cardiomegaly (Heart Hypertrophy) 01/2021 - 12/2003
11	Hypertrophy 01/2021 - 02/2005
11	Heart Failure 10/2020 - 10/2012
10	Myocardial Infarction 01/2018 - 07/2005
9	Dyslipidemias (Dyslipidemia) 12/2017 - 06/2003
8	COVID-19 09/2021 - 01/2020
8	Fibrosis (Cirrhosis) 01/2021 - 10/2006
7	Chronic Renal Insufficiency 01/2022 - 01/2013
7	Reperfusion Injury 01/2021 - 01/2007
7	Type 2 Diabetes Mellitus (MODY) 10/2020 - 01/2014
7	Coronary Artery Disease (Coronary Atherosclerosis) 01/2019 - 10/2005
6	Insulin Resistance 04/2022 - 01/2006
6	Chronic Hepatitis B 01/2022 - 08/2013
6	Breast Neoplasms (Breast Cancer) 01/2021 - 02/2017
6	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2017 - 03/2012
5	Non-alcoholic Fatty Liver Disease 04/2022 - 01/2019
5	Hyperplasia 01/2021 - 06/2014
5	Hypercholesterolemia 08/2017 - 10/2006
5	Hypoxia (Hypoxemia) 01/2016 - 06/2007
5	Ischemia 01/2013 - 07/2005
4	Atherosclerosis 09/2021 - 11/2012
4	Rheumatoid Arthritis 08/2021 - 01/2008
4	Atrial Fibrillation 01/2021 - 01/2012
4	Coronary Disease (Coronary Heart Disease) 01/2018 - 07/2007
4	Essential Hypertension 02/2012 - 10/2006
3	Chronic Kidney Failure (Chronic Renal Failure) 01/2022 - 01/2012
3	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2022 - 11/2014
3	Pulmonary Hypertension 01/2022 - 01/2017
3	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 01/2019
3	Arteriosclerosis 01/2020 - 06/2014
3	Carcinogenesis 01/2020 - 04/2011
3	Pain (Aches) 01/2020 - 01/2018
3	Carotid Artery Diseases 09/2019 - 07/2014
3	Stroke (Strokes) 05/2019 - 07/2007
3	Neointima 01/2019 - 01/2016
3	Diabetes Mellitus 01/2017 - 07/2012
3	Carcinoma (Carcinomatosis) 01/2015 - 01/2011
3	Myocardial Ischemia (Ischemic Heart Diseases) 02/2014 - 03/2012
3	Obesity 01/2013 - 06/2005
3	Necrosis 01/2012 - 02/2002
3	Body Weight (Weight, Body) 12/2008 - 02/2005
2	Acute Coronary Syndrome 12/2022 - 03/2013

Drug/Important Bio-Agent (IBA)

19	LipidsIBA 04/2022 - 10/2006
12	oxidized low density lipoproteinIBA 05/2022 - 06/2003
12	Proteins (Proteins, Gene)FDA Link 01/2021 - 02/2002
11	Angiotensin IIIBA 01/2021 - 02/2005
10	CytokinesIBA 01/2020 - 03/2003
10	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2018 - 10/2012
8	Glucose (Dextrose)FDA LinkGeneric 04/2022 - 04/2012
8	HomocysteineIBA 01/2021 - 01/2008
8	pro-brain natriuretic peptide (1-76)IBA 01/2021 - 01/2013
8	Blood Glucose (Blood Sugar)IBA 10/2020 - 07/2012
8	PPAR gammaIBA 02/2014 - 12/2004
7	Messenger RNA (mRNA)IBA 01/2022 - 02/2005
7	Pharmaceutical PreparationsIBA 08/2021 - 02/2003
7	HDL CholesterolIBA 01/2021 - 10/2011
7	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020 - 10/2005
7	MicroRNAs (MicroRNA)IBA 01/2020 - 07/2011
7	Pioglitazone (Actos)FDA Link 02/2014 - 02/2005
6	xuezhikangIBA 01/2021 - 10/2006
6	Triglycerides (Triacylglycerol)IBA 01/2021 - 01/2014
6	Biomarkers (Surrogate Marker)IBA 10/2020 - 05/2004
6	LDL CholesterolIBA 09/2019 - 01/2014
6	Insulin-Like Growth Factor I (IGF-1)IBA 01/2013 - 11/2004
5	LipopolysaccharidesIBA 01/2021 - 05/2012
5	CholesterolIBA 01/2019 - 01/2016
5	Troponin T (Troponin T1)IBA 01/2017 - 01/2012
5	Atorvastatin (Lipitor)FDA Link 12/2015 - 12/2005
5	PPAR alphaIBA 10/2010 - 12/2004
4	Dual-Specificity PhosphatasesIBA 01/2021 - 01/2019
4	CreatinineIBA 01/2021 - 11/2010
4	Hepatitis B e AntigensIBA 01/2020 - 01/2014
3	Uric Acid (Urate)IBA 11/2021 - 01/2014
3	C-Reactive ProteinIBA 01/2021 - 01/2014
3	Serum AlbuminIBA 01/2021 - 12/2012
3	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 03/2003
3	Antiviral Agents (Antivirals)IBA 01/2020 - 04/2004
3	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 01/2012
3	EnzymesIBA 01/2020 - 10/2019
3	InflammasomesIBA 01/2020 - 12/2014
3	Indicators and Reagents (Reagents)IBA 01/2020 - 01/2013
3	Rosuvastatin Calcium (Crestor)FDA Link 09/2019 - 11/2012
3	Insulin (Novolin)FDA Link 01/2019 - 06/2007
3	AldosteroneIBA 01/2018 - 10/2007
3	T-Cell Antigen Receptors (T-Cell Receptor)IBA 03/2016 - 09/2013
3	HDL LipoproteinsIBA 01/2016 - 10/2011
3	Complementary DNA (cDNA)IBA 01/2015 - 03/2002
3	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 04/2013 - 02/2008
2	Cyclin D1IBA 01/2022 - 05/2007
2	CateninsIBA 01/2022 - 01/2018
2	LigandsIBA 01/2022 - 11/2011

Therapy/Procedure

26	Therapeutics 08/2021 - 03/2003
4	Ligation 01/2017 - 02/2005
3	Renal Dialysis (Hemodialysis) 01/2022 - 01/2013
3	Transplantation 01/2020 - 05/2013